Stock listing

BOATS:CNXU Conexeu Sciences Inc. Stock

US listing (BOATS) of Conexeu Sciences Inc. · home listing NASDAQ:CNXU

Follow Conexeu Sciences Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:CNXU

$1.55 USD -0.53 (-25.5%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CNXU

Past 6 months -88.1% · daily closes, May 21, 2026 – Nov 20, 2026, adjusted for splits
Day range
$1.48 – $2.09 USDNov 20, 2026
Volume
682,700 sharesNov 20, 2026
Market cap
$47.79M USDAt the close on Nov 20, 2026 · price × 30.83M shares outstanding
Traded on an average day
$1.14M USDMedian day 234,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Conexeu Sciences Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CNXU · Home$1.55 USD-0.53 (-25.5%)682,700$2.09$2.09$1.48$2.08Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:CNXU · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.55-0.53-25.5%$2.09$2.09$1.48682,700
$2.08-0.28-11.9%$2.38$2.57$2.01576,700
$2.36+0.36+18.0%$2.08$2.36$2.00433,100
$2.00-0.21-9.5%$2.23$2.40$1.97196,400
$2.21+0.03+1.4%$2.19$2.21$1.95139,900
$2.180.000.0%$2.19$2.30$2.05193,000
$2.18-0.08-3.5%$2.22$2.39$1.93149,300
$2.26+0.04+1.8%$2.26$2.45$2.22240,200
$2.22-0.11-4.7%$2.29$2.30$2.01207,200
$2.33+0.07+3.1%$2.29$2.40$2.19219,800
$2.26+0.14+6.6%$2.11$2.34$2.10133,100
$2.12-0.10-4.5%$2.19$2.30$2.07212,000
$2.22-0.16-6.7%$2.38$2.40$2.12202,100
$2.38-0.02-0.8%$2.38$2.45$2.23230,600
$2.40-0.14-5.5%$2.70$2.75$2.26340,000
$2.54-0.29-10.2%$2.85$2.85$2.43517,300
$2.83-0.05-1.7%$2.94$3.07$2.79413,700
$2.88-0.07-2.4%$2.92$3.00$2.78340,200
$2.95+0.01+0.3%$2.96$3.00$2.83223,400
$2.94-0.16-5.2%$3.13$3.15$2.90299,700
$3.10-0.20-6.1%$3.22$3.30$3.08167,300
$3.30-0.03-0.9%$3.28$3.45$3.06207,600
$3.33+0.34+11.4%$3.05$3.59$3.00416,700
$2.99-0.30-9.1%$3.33$3.60$2.95596,800
$3.29+0.23+7.5%$3.27$3.35$3.05386,400
$3.06-0.89-22.5%$3.96$4.00$3.05663,900
$3.95+0.30+8.2%$3.66$4.05$3.40600,300
$3.65+0.34+10.3%$3.44$4.36$3.421,147,800
$3.31-0.46-12.2%$3.78$3.97$3.30284,300
$3.77-0.12-3.1%$4.10$4.10$3.65362,800
$3.89+0.44+12.8%$3.50$4.22$3.47427,700
$3.45-0.19-5.2%$3.64$3.68$3.30243,500
$3.64-0.02-0.5%$3.68$3.75$3.47239,000
$3.66+0.54+17.3%$3.33$3.74$3.15328,300
$3.12+0.02+0.6%$3.07$3.24$3.05171,200
$3.10-0.22-6.6%$3.33$3.41$3.10114,300
$3.32-0.25-7.0%$3.51$3.60$3.3295,800
$3.57-0.14-3.8%$3.68$3.74$3.45194,900
$3.71-0.06-1.6%$3.74$3.84$3.60241,500
$3.77-0.12-3.1%$3.89$3.90$3.69179,600
$3.89-0.07-1.8%$4.03$4.11$3.82111,200
$3.96-0.25-5.9%$4.09$4.22$3.82163,600
$4.21-0.19-4.3%$4.37$4.50$3.86235,100
$4.40-0.35-7.4%$4.81$4.87$4.40158,200
$4.75-0.21-4.2%$5.02$5.02$4.62138,300
$4.96-0.34-6.4%$5.36$5.46$4.95608,400
$5.30+0.68+14.7%$4.70$5.47$4.70233,300
$4.62+0.17+3.8%$4.42$4.70$4.42114,700
$4.45-0.55-11.0%$5.00$5.00$4.36124,800
$5.00+0.54+12.1%$4.50$5.11$4.46191,600
$4.46+0.21+4.9%$4.30$4.54$4.30114,100
$4.25-0.21-4.7%$4.38$4.50$4.19166,800
$4.46-0.22-4.7%$4.69$4.82$4.43191,200
$4.68-0.29-5.8%$4.95$4.99$4.65276,000
$4.97-0.30-5.7%$5.26$5.58$4.85249,500
$5.27-0.29-5.2%$5.49$5.79$5.20305,000
$5.56-0.31-5.3%$5.79$6.10$5.38224,800
$5.87-1.31-18.2%$7.11$7.25$5.86352,800
$7.18+0.11+1.6%$7.31$7.37$6.87189,900
$7.07+0.03+0.4%$7.00$7.10$6.73176,300
$7.04+0.06+0.9%$7.03$7.51$6.94227,000
$6.98-0.57-7.5%$7.50$7.50$6.94290,700
$7.55-0.26-3.3%$7.91$8.15$7.40321,214
$7.81-1.08-12.1%$8.77$9.189$7.70411,023
$8.89-0.54-5.7%$9.42$10.29$8.65395,600
$9.43+0.47+5.2%$8.98$9.80$8.93261,100
Ticker
BOATS:CNXU
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
BOATS
Currency
USD

What changed lately

Latest news

All Conexeu Sciences Inc. news

Conexeu Sciences Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
15 in the last 12 months · 15 in all · newest Nov 19, 2026 · oldest 2026
Decks
1 deck · latest 2026

Where Conexeu Sciences Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CNXU · Home listingNASDAQUnited StatesUSD
BOATS:CNXU · This pageBOATSUnited StatesUSD

Valuation

Price/book 8.2× against a median of 1.1×: the highest of 10 Medical devices & supplies companies shown. balance Jul 31, 2026 · price Nov 20, 2026

Enterprise value
$45.82M USD
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
8.2×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
2.08

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Conexeu Sciences Inc. · NASDAQ:CNXUUS$47.79MUS$45.82Mn/an/an/a8.2×n/a0.0×2.08
Theraclion SA · EURONEXT:ALTHEUS$50.29MUS$49.99Mn/a38.4×n/an/a−479.8%n/an/a
Senzime AB · OMXSTO:SEZIUS$49.96MUS$49.20Mn/a4.7×n/a2.0×−92.2%0.1×n/a
Hyperfine, Inc. · NASDAQ:HYPRUS$49.73MUS$25.21Mn/a1.3×n/a1.6×−156.4%0.4×1.67
Modulight Oyj · OMXHEX:MODUUS$48.72MUS$43.29Mn/a5.9×23.0×1.1×−50.1%0.0×n/a
DRTECH Corp. · KRX:214680US$48.37MUS$31.72Mn/a0.3×34.4×0.8×−9.9%0.3×n/a
Hironic Co.Ltd · KRX:149980US$48.36MUS$32.54M14.4×1.2×6.7×0.8×12.2%0.0×n/a
Venus Medtech (Hangzhou), Inc. Class H · HKEX:2500US$48.32MUS$65.50Mn/a1.4×n/a0.2×−132.9%0.1×n/a
Medimaging Integrated Solution Inc. · TWSE:6796US$48.03MUS$43.05M111×2.1×28.6×1.9×2.1%0.5×n/a
Microbot Medical Inc. · NASDAQ:MBOTUS$45.67M−US$16.16Mn/a−38.6×n/a0.7×n/a0.0×1.82
RenovoRx, Inc. · NASDAQ:RNXTUS$45.45MUS$35.27Mn/a12.7×n/a4.9×−469.0%0.0×1.71
Median of the othersUS$48.37MUS$39.16M62.5×1.8×25.8×1.1×−92.2%0.1×1.71

Forecasts

1 strong buy · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
20.00 USD · Analysts' mean
EPS, year to Oct 2026
-0.40 · 1 analyst

Team and board

Officers

OfficerRole
Miles D. HarrisonPresident & Chief Executive Officer
Claudia Chavez-MunozCo-Founder and Chief Science Officer
David BogartChief Commercial Officer and Director

Board

DirectorRole
Daniel M. BradburyChairman of the Board of Directors
Aaron FarbergDirector
David BogartChief Commercial Officer and Director
Jeff SharpeDirector
Sebastian PurcellDirector

Events

QuarterResultsShare move
Q2 2026Sep 14, 2026 · After close−11.0%
Q1 2026Jul 1, 2026−0.6%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (2026)Investor deck26 slides2026

Open Decks

Financings

RaiseDate
Private placement of units (and special warrants for certain Canadian subscribers)
Closed: US$5M raised · US$3 a unit · 1 warrant at US$3 for 24 months
Buyers: Miles Harrison; David Bogart
Insiders: Led by existing shareholders including management and directors; $250,000 of subscriptions from certain management and directors held in escrow pending stockholder approval
Use of proceeds: Working capital and general corporate purposes, including manufacturing scale-up, regulatory testing and preclinical work for planned FDA 510(k) submission
Oct 15, 2026

Open Financings · Read by 6ix AI from the company's releases

Filings

FilingDateTypeFiled with
S-1 · Registration statementNov 19, 2026Offer documentSEC
8-K · Current reportNov 16, 2026Current reportSEC
DNov 5, 2026Other filingsSEC
DNov 5, 2026Other filingsSEC
424B3 · ProspectusOct 29, 2026Offer documentSEC
8-K · Current reportOct 27, 2026FinancingSEC
DOct 20, 2026Other filingsSEC
424B3 · ProspectusOct 20, 2026Offer documentSEC
8-K · Current reportOct 20, 2026FinancingSEC
4 · Change in ownershipOct 19, 2026Insider tradeSEC
All 92 filings
FilingDateTypeFiled with
DSep 29, 2026Other filingsSEC
4 · Change in ownershipSep 28, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedSep 15, 2026Big-stake noticeSEC
4 · Change in ownershipSep 15, 2026Insider tradeSEC
DSep 15, 2026Other filingsSEC
424B3 · ProspectusSep 14, 2026Offer documentSEC
10-Q · Quarterly reportSep 14, 2026Quarterly reportSEC
424B3 · ProspectusSep 10, 2026Offer documentSEC
8-K · Current reportSep 10, 2026FinancingSEC
4/A · Change in ownership, amendedSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedSep 4, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeSep 4, 2026Big-stake noticeSEC
DAug 31, 2026Other filingsSEC
SCHEDULE 13D · Big-stake noticeAug 18, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 18, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
DJul 30, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeJul 28, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeJul 20, 2026Big-stake noticeSEC
8-K · Current reportJul 7, 2026Current reportSEC
DJun 29, 2026Other filingsSEC
DJun 29, 2026Other filingsSEC
3 · Initial statement of ownershipJun 29, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 24, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 23, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
424B3 · ProspectusJun 15, 2026Offer documentSEC
10-Q · Quarterly reportJun 15, 2026Quarterly reportSEC
D/AJun 12, 2026Other filingsSEC
DJun 10, 2026Other filingsSEC
8-K · Current reportJun 9, 2026FinancingSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 27, 2026Insider tradeSEC
4 · Change in ownershipMay 26, 2026Insider tradeSEC
DMay 21, 2026Other filingsSEC
DMay 21, 2026Other filingsSEC
4 · Change in ownershipMay 15, 2026Insider tradeSEC
424B3 · ProspectusMay 15, 2026Offer documentSEC
8-K · Current reportMay 15, 2026FinancingSEC
424B3 · ProspectusMay 14, 2026Offer documentSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveMay 12, 2026Other filingsSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 11, 2026Insider tradeSEC
424B4 · ProspectusMay 11, 2026Offer documentSEC
CERT · Exchange's certificate of listingMay 11, 2026Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeMay 11, 2026Other filingsSEC
S-1/A · Registration statement, amendedApr 17, 2026Offer documentSEC
S-1/A · Registration statement, amendedApr 9, 2026Offer documentSEC
S-1/A · Registration statement, amendedApr 6, 2026Offer documentSEC
DMar 31, 2026Other filingsSEC
S-1/A · Registration statement, amendedMar 26, 2026Offer documentSEC
DMar 20, 2026Other filingsSEC
S-1/A · Registration statement, amendedMar 4, 2026Offer documentSEC
C-ARFeb 27, 2026Other filingsSEC
DFeb 26, 2026Other filingsSEC
DFeb 4, 2026Other filingsSEC
S-1/A · Registration statement, amendedFeb 3, 2026Offer documentSEC
S-1 · Registration statementNov 28, 2025Offer documentSEC
DNov 20, 2025Other filingsSEC
DNov 12, 2025Other filingsSEC
C-UOct 10, 2025Other filingsSEC
C-USep 23, 2025Other filingsSEC
C/AJul 30, 2025Other filingsSEC
CJul 30, 2025Other filingsSEC
D/AJul 2, 2025Other filingsSEC
DJun 13, 2025Other filingsSEC
DMay 8, 2025Other filingsSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Conexeu Sciences Inc.’s releases · as of Oct 15, 2026

Common shares
30,831,698
Fully diluted
32,498,365

Fully diluted

LineSharesAs of
Common shares30,831,698Oct 15, 2026
Warrants1,666,667Oct 15, 2026

Warrants and options

Lot
Warrants · US$3.00 · expire about Oct 2028

Share count over time

CountShares
Oct 15, 202630,831,698

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard357K1.3%US$1.28MSep 30, 2026
Geode Capital151K0.53%US$537KSep 30, 2026
Renaissance Technologies114K0.41%US$409KSep 30, 2026
UBS51,6960.18%US$185KSep 30, 2026
Northern Trust32,6920.12%US$117KSep 30, 2026
State Street23,2000.08%US$82,824Sep 30, 2026
Citadel13,5800.05%US$48,481Sep 30, 2026
Axq Capital, LP12,8120.05%US$45,739Sep 30, 2026
Osaic Holdings, Inc.10,5770.04%US$39,152Sep 30, 2026
Jefferies Financial Group Inc.10,0000.04%US$35,700Sep 30, 2026
All 30 holders
HolderSharesOf the companyValueAs of
Wells Fargo2,600<0.01%US$9,282Sep 30, 2026
Jones Financial Companies Lllp2,100<0.01%US$8,169Sep 30, 2026
JPMorgan1,115<0.01%US$4,137Sep 30, 2026
Tower Research Capital LLC (TRC)1,041<0.01%US$3,716Sep 30, 2026
Paladin Partners, LLC1,000<0.01%US$3,570Sep 30, 2026
Hollencrest Capital Management1,000<0.01%US$3,570Sep 30, 2026
RBC736<0.01%US$3,000Sep 30, 2026
BlackRock716<0.01%US$2,556Sep 30, 2026
Colonial Trust Advisors325<0.01%US$1,160Sep 30, 2026
Continuum Advisory, LLC289<0.01%US$1,032Sep 30, 2026
Farther Finance Advisors, LLC281<0.01%US$1,003Sep 30, 2026
SOA Wealth Advisors, LLC.200<0.01%US$714Sep 30, 2026
Gen-Wealth Partners Inc200<0.01%US$714Sep 30, 2026
SimplyRIA Advisor Network159<0.01%US$568Sep 30, 2026
Morgan Stanley155<0.01%US$553Sep 30, 2026
Pinnacle Financial Group, Inc.100<0.01%US$357Sep 30, 2026
PNC Financial Services Group, Inc.100<0.01%US$357Sep 30, 2026
Bartlett & Co. Wealth Management LLC100<0.01%US$357Sep 30, 2026
Global Retirement Partners, LLC33<0.01%US$118Sep 30, 2026
BNP Paribas1<0.01%US$4Sep 30, 2026

Insider trades

TradeTradeSharesPriceValueDate
Purcell Lynn Sebastian
Director, 10% owner
Buy166,666USD 3.00US$500KOct 15, 2026
Purcell Lynn Sebastian
Director, 10% owner
Buy202,500USD 0.80US$162KJun 18, 2026

Big stakes

StakeStakeSharesDateFiling
OnePointTwo Capital Performance LLC12.30%3.36MJun 30, 2026Schedule 13G
Wright Michael G.12.10%3.28MJun 30, 2026Schedule 13G
Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund9.99%4.31MJun 30, 2026Schedule 13G
David Bogart8.10%2.29MJun 30, 2026Schedule 13G
OnePointTwo Capital Ventures LLC6.80%1.88MJun 30, 2026Schedule 13G
Paisley Capital Holdings Corp6.70%1.8MJun 30, 2026Schedule 13G
OnePointTwo Capital Ventures II LLC5.50%1.48MJun 30, 2026Schedule 13G
Jeffrey Sharpe5.20%1.5MSep 14, 2026Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Andrew Costa
Other companies: Tigo Energy, Inc. (Co-Chief Operating Officer · Aug 5, 2021 – Apr 25, 2022 · Past)
Director · Since at least Jun 15, 2026
Aaron FarbergDirector · Since at least May 11, 2026
Ana Bastiani-PosnerDirector · Since at least Jun 15, 2026
April BurkeDirector · Since at least Jun 15, 2026
Brian Keith PilcherChief Medical Officer · Since at least May 11, 2026
Claudia Chavez-MunozChief Science Officer · Since at least May 11, 2026
Daniel M. BradburyChairman of the Board of Directors · Since at least Nov 19, 2026
David BogartChief Commercial Officer, Director · Since at least Sep 25, 2026
Jeff SharpeDirector · Since at least May 11, 2026
Lynn Sebastian PurcellDirector · Since at least May 11, 2026
All 14 people
PersonSeat
Miles D. HarrisonPresident & Chief Executive Officer · Since at least May 11, 2026
Sebastian PurcellDirector · Since at least Nov 20, 2026
Stephen Douglas InouyeCFO, Secretary, and Treasurer · Since at least May 11, 2026
Zbigniew Paul LorencDirector · Since at least May 11, 2026

Open People

Log in to ask 6ix AI your own questions about Conexeu Sciences Inc.